Inventor profile of:

Takuya Osada

City:

Durham, North Carolina

Country:

United States

Published Applications:

18

Last publication date:

2025-06-26

Top Assignees for applications by Takuya Osada

The entities that hold a legal rights for patent applications filed by inventor Osada Takuya:

Recent patent applications by Osada Takuya

Takuya Osada from Durham, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-06-26
US20250205467A1
Human necessities

SYSTEMS AND METHODS FOR THE TREATMENT OF CANCER USING ULTRASOUND

#2 | 2022-07-21
US20220226666A1
Human necessities

X-ray psoralen activated cancer therapy (X-PACT)

#3 | 2021-10-28
US20210330773A1
Human necessities

VACCINES AGAINST ANTIGENS INVOLVED IN THERAPY RESISTANCE AND METHODS OF USING SAME

#4 | 2021-03-18
US20210077606A1
Human necessities

Vaccines against an oncogenic isoform of HER2 (ErbB2) and methods of using the same

#5 | 2021-03-11
US20210069309A1
Human necessities

VACCINES AGAINST AN ONCOGENIC ISOFORM OF ESR1 AND METHODS OF USING THE SAME

#6 | 2020-01-09
US20200009398A1
Human necessities

X-ray psoralen activated cancer therapy (X-PACT)

#7 | 2019-01-24
US20190022204A1
Human necessities

Cancer vaccines and methods of delivery

#8 | 2018-12-06
US20180344850A1
Human necessities

X-RAY psoralen activated cancer therapy (X-PACT) with associated treatments

#9 | 2018-12-06
US20180344824A1
Human necessities

Vaccines against an oncogenic isoform of HER2 (ErbB2) and methods of using the same

#10 | 2018-11-15
US20180326030A1
Human necessities

Vaccines against an oncogenic isoform of ESR1 and methods of using the same

#11 | 2018-11-01
US20180311329A1
Human necessities

Vaccines against antigens involved in therapy resistance and methods of using same

#12 | 2018-10-04
US20180282736A1
Chemistry; metallurgy

HER3 VACCINE VECTOR COMPOSITIONS AND METHODS OF USING THE SAME

#13 | 2018-04-05
US20180094050A1
Chemistry; metallurgy

Vaccines against HER3 antigens and methods of using the same

#14 | 2017-07-13
US20170196953A1
Human necessities

VACCINES AGAINST AN ONCOGENIC ISOFORM OF HER2 (ErbB2) AND METHODS OF USING THE SAME

#15 | 2017-07-13
US20170196952A1
Human necessities

VACCINES AGAINST AN ONCOGENIC ISOFORM OF ESR1 AND METHODS OF USING THE SAME

#16 | 2017-06-08
US20170157418A1
Human necessities

X-ray psoralen activated cancer therapy (X-PACT)

#17 | 2017-01-19
US20170015758A1
Chemistry; metallurgy

Compositions And Methods For Modulating And Redirecting Immune Responses

#18 | 2014-12-25
US20140377261A1
Human necessities

Vaccines against antigens involved in therapy resistance and methods of using same

InventorID:

1014170 ⎘